<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Pieters, M.H.</title>
    <link>http://repub.eur.nl/res/aut/3661/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Genetic risk factors in infertile men with severe oligozoospermia and azoospermia (Article)</title>
      <link>http://repub.eur.nl/res/pub/9814/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Male infertility due to severe oligozoospermia and azoospermia
      has been associated with a number of genetic risk factors. METHODS: In
      this study 150 men from couples requesting ICSI were investigated for
      genetic abnormalities, such as constitutive chromosome abnormalities,
      microdeletions of the Y chromosome (AZF region) and mutations in the
      cystic fibrosis transmembrane conductance regulator (CFTR) gene. RESULTS:
      Genetic analysis identified 16/150 (10.6%) abnormal karyotypes, 8/150
      (5.3%) AZFc deletions and 14/150 (9.3%) CFTR gene mutations. An abnormal
      karyotype was found both in men with oligozoospermia and azoospermia: 9
      men had a sex-chromosomal aneuploidy, 6 translocations were identified and
      one marker chromosome was found. Y chromosomal microdeletions were mainly
      associated with male infertility, due to testicular insufficiency. All
      deletions identified comprised the AZFc region, containing the Deleted in
      Azoospermia (DAZ) gene. CFTR gene mutations were commonly seen in men with
      congenital absence of the vas deferens, but also in 16% of men with
      azoospermia without any apparent abnormality of the vas deferens.
      CONCLUSIONS: A genetic abnormality was identified in 36/150 (24%) men with
      extreme oligozoospermia and azoospermia. Application of ICSI in these
      couples can result in offspring with an enhanced risk of unbalanced
      chromosome complement, male infertility due to the transmission of a
      Y-chromosomal microdeletion, and cystic fibrosis if both partners are CFTR
      gene mutation carriers. Genetic testing and counselling is clearly
      indicated for these couples before ICSI is considered.</description>
    </item> <item>
      <title>A prospective randomized comparison of sequential versus monoculture systems for in-vitro human blastocyst development (Article)</title>
      <link>http://repub.eur.nl/res/pub/9984/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Extending the period of in-vitro culture to the blastocyst
      stage may improve implantation rates in IVF treatment. Recognition of the
      dynamic nature of early embryo metabolism has led to the development of
      commercially available sequential culture systems. However, their improved
      efficacy over monoculture systems remains to be demonstrated in
      prospective studies. METHODS: Embryos obtained from 158 women undergoing
      IVF treatment were randomized by sealed envelopes to culture in one of
      three systems: (A) culture for 5 days in our own monoculture medium
      (Rotterdam medium); (B) culture for 3 days in Rotterdam medium followed by
      2 days in fresh Rotterdam medium; (C) culture for 5 days using the
      commercially available G1/G2 sequential culture system. RESULTS: There
      were no significant differences in blastulation, implantation or pregnancy
      rates between the three tested culture systems. CONCLUSION: The employed
      monoculture system is as effective as the G1/G2 sequential system for the
      culture of blastocysts for IVF.</description>
    </item> <item>
      <title>Surgical sperm retrieval and intracytoplasmic sperm injection as treatment of obstructive azoospermia (Article)</title>
      <link>http://repub.eur.nl/res/pub/8815/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Male genital tract obstructions may result from infections, previous
          inguinal and scrotal surgery (vasectomy) and congenital bilateral absence
          of the vas deferens (CBAVD). Microsurgery can sometimes be successful in
          treating the obstruction. In other cases and in cases of failed surgical
          intervention, the patient can be treated by microsurgical or percutaneous
          epididymal sperm aspiration (MESA, PESA) or testicular sperm extraction
          (TESE) and intracytoplasmic sperm injection (ICSI). We present the results
          of 39 ICSI procedures for obstructive azoospermia in 24 couples. The
          aetiology of the obstruction was failed microsurgery in 11 patients, CBAVD
          in nine and genital infections in four. Sperm retrieval was accomplished
          via MESA in four cases, PESA in 18 cases and via TESE in 11 cases. TESE
          was only applied when PESA failed to produce enough spermatozoa for
          simultaneous ICSI. In six patients, the ICSI procedure was performed with
          cryopreserved spermatozoa after an initial PESA procedure. Fertilization
          occurred in 47% of the metaphase II oocytes; embryo transfer was performed
          in 92% of procedures and resulted in a clinical pregnancy in 13/39
          procedures. Ongoing pregnancy was achieved in 10/39 procedures. One
          pregnancy was terminated early after prenatal investigation showed a
          cytogenetic abnormality (47,XX+18, Edwards syndrome). The other nine
          pregnancies resulted in the live birth of 10 children, without any
          congenital abnormalities. Epididymal and testicular retrieved spermatozoa
          were successfully used for ICSI to treat obstructive azoospermia, and
          resulted in an ongoing pregnancy in 10 of 24 couples (41.6%) after 39 ICSI
          procedures, a success rate of 25.6% per treatment cycle and of 27.7% per
          embryo transfer.</description>
    </item> <item>
      <title>Determination of the parent of origin in nine cases of prenatally detected chromosome aberrations found after intracytoplasmic sperm injection (Article)</title>
      <link>http://repub.eur.nl/res/pub/8686/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Prenatal cytogenetic analysis of 71 fetuses conceived by intracytoplasmic
          sperm injection (ICSI) resulted in the detection of nine (12.7%)
          chromosome aberrations including two cases of 47,XXY, four cases involving
          a 45,X cell line and three autosomal trisomies. Molecular analysis of the
          parental origin of the deleted or supernumerary chromosome was performed
          by using polymorphic microsatellite markers. Six cases involving a sex
          chromosome abnormality were found to be of paternal origin while the two
          trisomic cases that could be analysed were of maternal origin. Two cases
          involved the same infertile couple who had two consecutive ICSI
          pregnancies terminated because of a chromosome abnormality. The replaced
          embryos in both cases originated from a single batch of ICSI fertilized
          oocytes of which part was used to initiate the first pregnancy and part
          was cryopreserved and used to initiate the second pregnancy.</description>
    </item> <item>
      <title>Intracytoplasmic sperm injection (ICSI) and chromosomally abnormal spermatozoa (Article)</title>
      <link>http://repub.eur.nl/res/pub/8687/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>An infertile couple was referred for intracytoplasmic sperm injection
          (ICSI) because of primary infertility and oligoasthenoteratozoospermia
          (OAT) in the male. It was observed that although the sperm cells presented
          with an unusual head size and multiple tails they were able to fertilize
          the oocytes after ICSI. Subsequent molecular cytogenetic analysis
          demonstrated de-novo chromosome abnormalities in virtually all sperm cells
          with 40% diploidy and 24% triploidy in addition to aneuploidy for the sex
          chromosomes.</description>
    </item> <item>
      <title>Two cases of Robertsonian translocations in oligozoospermic males and their consequences for pregnancies induced by intracytoplasmic sperm injection (Article)</title>
      <link>http://repub.eur.nl/res/pub/8719/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Two case histories are presented documenting structural chromosome
          abnormalities in infertile males. The abnormalities were detected only
          after application of intracytoplasmic sperm injection (ICSI) was
          repeatedly unsuccessful or resulted in an abnormal pregnancy. A mosaic
          Robertsonian translocation 45,XY,der(13;13)(q10;
          q10)/46,XY,t(13;13)(p10;p10), der(13p;13p) incompatible with normal
          offspring was found in a male with extreme oligozoospermia after three
          subsequent ICSI treatments were unsuccessful and one had resulted in a
          spontaneous abortion. A second case involved a Robertsonian translocation
          45,XY,der(13;14)(q10;q10) which was detected in a male with extreme
          oligozoospermia after ultrasound abnormalities were found in an
          ICSI-induced twin pregnancy. Amniocentesis showed an unbalanced
          46,XY,+13,der(13;14)(q10;q10) karyotype in one twin and a Robertsonian
          45,XX,der(13;14)(q10;q10) karyotype in the other twin. Chromosome analysis
          of males with abnormal sperm characteristics is advised prior to ICSI.</description>
    </item>
  </channel>
</rss>